BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12032828)

  • 1. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
    Heckman CA; Mehew JW; Boxer LM
    Oncogene; 2002 May; 21(24):3898-908. PubMed ID: 12032828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
    Duan H; Heckman CA; Boxer LM
    Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2.
    Heckman CA; Cao T; Somsouk L; Duan H; Mehew JW; Zhang CY; Boxer LM
    Cancer Res; 2003 Oct; 63(20):6666-73. PubMed ID: 14583460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.
    Heckman CA; Wheeler MA; Boxer LM
    Oncogene; 2003 Sep; 22(39):7891-9. PubMed ID: 12970736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
    Griffin BD; Moynagh PN
    Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
    Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
    Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
    Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
    Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha induces gamma-glutamyltransferase expression via nuclear factor-kappaB in cooperation with Sp1.
    Reuter S; Schnekenburger M; Cristofanon S; Buck I; Teiten MH; Daubeuf S; Eifes S; Dicato M; Aggarwal BB; Visvikis A; Diederich M
    Biochem Pharmacol; 2009 Feb; 77(3):397-411. PubMed ID: 18996094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.
    Heckman CA; Duan H; Garcia PB; Boxer LM
    Oncogene; 2006 Feb; 25(6):888-98. PubMed ID: 16186795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.
    Yan Y; Dalmasso G; Sitaraman S; Merlin D
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
    Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1 induces glut1 transcription through enhanced interaction between Sp1 and NF-kappaB transcription factors.
    Kao YS; Fong JC
    Cell Signal; 2008 Apr; 20(4):771-8. PubMed ID: 18249093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
    Lok CN; Lang AJ; Mirski SE; Cole SP
    Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma.
    Arcinas M; Heckman CA; Mehew JW; Boxer LM
    Cancer Res; 2001 Jul; 61(13):5202-6. PubMed ID: 11431360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NF-kappaB oligonucleotide "decoys" on gene expression in P7 rat hippocampus after hypoxia/ischemia.
    Qiu J; Hu X; Nesic O; Grafe MR; Rassin DK; Wood TG; Perez-Polo JR
    J Neurosci Res; 2004 Jul; 77(1):108-18. PubMed ID: 15197744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factor-kappaB in human HPV-18 E6-positive HEp-2 cells.
    Singh S; Bhat MK
    Biochem Biophys Res Commun; 2004 May; 318(2):346-53. PubMed ID: 15120608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up regulation of GW112 Gene by NF kappaB promotes an antiapoptotic property in gastric cancer cells.
    Kim KK; Park KS; Song SB; Kim KE
    Mol Carcinog; 2010 Mar; 49(3):259-70. PubMed ID: 19908244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis.
    Delhalle S; Deregowski V; Benoit V; Merville MP; Bours V
    Oncogene; 2002 May; 21(24):3917-24. PubMed ID: 12032830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the infection-responsive bovine lactoferrin promoter.
    Zheng J; Ather JL; Sonstegard TS; Kerr DE
    Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.